Tokyo, Jan. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060517) titled 'Efficacy of Brolucizumab for Proliferative Diabetic Retinopathy and Changes in Aqueous Humor Cytokine Levels: A Clinical Study' on Jan. 30.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Gunma University
Condition:
Condition - Proliferative Diabetic Retinopathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the efficacy and safety of brolucizumab in proliferative diabetic retinopathy. In addition, v...